Mesoblast Ltd
F:LWB1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mesoblast Ltd
F:LWB1
|
AU |
|
Note AB (publ)
F:NQA
|
SE |
|
Kingfisher PLC
F:KFI1
|
UK |
|
W
|
Westpac Banking Corp
XMUN:WBC
|
AU |
|
D
|
Dollar Tree Inc
DUS:DT3
|
US |
|
L
|
Lumentum Holdings Inc
XBER:LU2
|
US |
|
P
|
Prysmian SpA
DUS:AEU
|
IT |
|
Pliant Therapeutics Inc
NASDAQ:PLRX
|
US |
Wall St Price Targets
LWB1 Price Targets Summary
Mesoblast Ltd
According to Wall Street analysts, the average 1-year price target for LWB1 is 20.7 EUR with a low forecast of 16.43 EUR and a high forecast of 27.15 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LWB1's stock price target?
Price Target
20.7
EUR
According to Wall Street analysts, the average 1-year price target for LWB1 is 20.7 EUR with a low forecast of 16.43 EUR and a high forecast of 27.15 EUR.
What is the Revenue forecast for Mesoblast Ltd?
Projected CAGR
117%
Over the last 13 years, the compound annual growth rate for Revenue has been -6%. The projected CAGR for the next 6 years is 117%.
What is the Gross Profit forecast for Mesoblast Ltd?
Projected CAGR
192%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -2%. The projected CAGR for the next 3 years is 192%.
